Facebook Inc (FB)

pos +0.86
Today's Range: 114.30 - 116.48 | FB Avg Daily Volume: 21,617,400
Last Update: 12/02/16 - 1:07 PM EST
Volume: 16,197,390
YTD Performance: 13.15%
Open: $115.11
Previous Close: $115.10
52 Week Range: $72.00 - $122.20
Oustanding Shares: 2,882,167,478
Market Cap: 341,306,272,745
6-Month Chart
TheStreet Ratings Grade for FB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 24 24 25 24
Moderate Buy 4 4 4 4
Hold 3 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.32 1.27 1.26 1.27
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 45.72
Price Earnings Comparisons:
FB Sector Avg. S&P 500
45.72 45.70 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.90% 10.42% 151.90%
Revenue 43.80 2.50 0.52
Net Income 25.40 68.60 3.06
EPS 17.30 64.50 2.98
Earnings for FB:
Revenue 17.93B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.09 $0.89 $3.30 $4.36
Number of Analysts 9 5 10 10
High Estimate $1.17 $0.91 $3.42 $4.77
Low Estimate $1.00 $0.86 $3.05 $3.74
Prior Year $0.59 $0.57 $1.49 $3.30
Growth Rate (Year over Year) 84.56% 56.14% 121.74% 31.93%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

Jim Cramer

 | Nov 11, 2016 | 6:55 AM EST
There are a lot of under-owned stocks out there.

Eric Jhonsa

 | Nov 10, 2016 | 7:57 PM EST
The GPU leader's results and guidance indicate a very strong debut for its latest chips, as well as swelling interest in 4K gaming and AI projects.

James "Rev Shark" DePorre

 | Nov 10, 2016 | 11:03 AM EST
The mood has been overly emotional, and there has been plenty of machine action.

Eric Jhonsa

 | Nov 9, 2016 | 8:23 PM EST
Just weeks after reportedly seeing potential suitors walk away, Twitter names a new second-in-command.

Jim Cramer

 | Nov 8, 2016 | 12:55 PM EST
Jim Cramer says LinkedIn could face potential threats to its job openings business, including a threat from Facebook.

Jim Cramer

 | Nov 7, 2016 | 4:03 PM EST
After the election passes we are going to talk about companies again -- and these have done well.

Jim Cramer

 | Nov 7, 2016 | 2:39 PM EST
The market's ability to forgive and forget is legion, especially with growth stocks that keep growing.

Guy Ortmann

 | Nov 7, 2016 | 12:16 PM EST
Which stocks have shown these patterns in the past week.

Jim Cramer

 | Nov 7, 2016 | 11:25 AM EST
Avoid stocks with poor numbers that would suffer under a Clinton administration.

Doug Kass

 | Nov 3, 2016 | 3:44 PM EDT
The U.S. dollar strengthened. The price of crude oil continued to roll over: down $0.66 to $44.68. Ag commodities: wheat down $0.05, corn up $0.02, soybeans up $0.03 and oats down $0.04. Lumber up $5. Bonds got schmeissed (iShares Barclays 20+ Yr Treas.Bond ETF (TLT) down a beaner) after staging a two-day recovery. The 10-year U.S. Treasury rose by 2 basis points in yield while the long bond advanced by 4 basis points. The 2s/10s spread rose back to 100 bps. Municipals were flat to higher. Junk bond prices edged a bit higher as well. Blackstone/GSO Strategic Credit Fund (BGB)  up $0.02. Banks were mixed. Our Trade of the Week made a morning move higher -- and then dropped to new daily lows. I added on the short side. Financial Select Sector SPDR Fund (XLF) up by $0.08. Insurance was very strong after a Lincoln National (LNC) beat (I remain small short). Hartford Financial (HIG) lacked this time. Brokerages are surprisingly strong, led by Goldman Sachs (GS) . Old tech down - with Comcast (CSCO) , Microsoft (MSFT) and Intel (INTC) lower. Retail still stinking up the joint with Nordstrom (JWN) , Target (TGT) , Foot Locker (FL) et al. notably weaker. I added to a poorly performing JC Penney (JCP) today. Awful sentiment in biotech, pharma and generic -- for obvious reasons. Biotech was a biowreck, breaking support levels. Allergan (AGN)  , Valeant Pharmaceuticals (VRX)  , Merck (MCK) etc lower. Speculative biotech like Sage Therapeutics (SAGE)  , Portula Pharmaceuticals (PTLA) ,  Acadia Pharmaceuticals (ACAD) , Aerie Pharmaceut
As a technician, I look for trends and patterns that repeat over and over again. Some are ...
Market looks like it will open ever so slightly down after an inline Jobs report that saw ...
There was nothing in today's November jobs report that should divert its path toward an ex...
Overall the jobs news was mostly inline but the household rate dropped sharply to 4.6% fro...


News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.